Inflammatory Response Research

About:

Inflammatory Response Research focuses on pharmaceutical products for the treatment of inflammatory disorders.

Description:

Inflammatory Response Research is a drug development company focused on pharmaceutical products for the treatment of inflammatory disorders and conditions. Their initial product is an oral combination of levocetirizine (Xyzal) and montelukast (Singulair) at specific dosing for the treatment of influenza. Parallel research is focused on an intravenous (IV) preparation for the treatment of traumatic brain injury and severe cases of influenza. IRR was founded in 2011 and is headquartered in Santa Barbara, California.

Total Funding Amount:

$1.84M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Santa Barbara, California, United States

Founded Date:

2011-01-01

Contact Email:

bcmay(AT)irrinc.net

Founders:

Loriel May

Number of Employees:

1-10

Last Funding Date:

2017-11-20

IPO Status:

Private

Industries: